Spheramine (BAY86-5280)

BIOLOGICAL2 trials

Sponsors

Bayer

Conditions

Parkinson DiseaseParkinson''s Disease

Phase 2

STEPS Trial - Spheramine Safety and Efficacy Study

TerminatedNCT00206687

BayerParkinson Disease

Start: 2003-01-08End: 2012-05-14Updated: 2024-10-31

Pilot Study of Safety and Efficacy of Spheramine

TerminatedNCT00761436

BayerParkinson''s Disease

Start: 2000-02-29End: 2012-05-14Updated: 2021-04-08

Related Papers

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

2011-05-10110 citations